Pfizer to pay $35M to settle off-label marketing allegations
August 06, 2014 at 14:00 PM EDT
Pfizer Inc. has agreed to pay $35 million to settle allegations of improper marketing and promotion of its immunosuppressive drug Rapamune, according to the New York Attorney General's Office...